ABOS
ABOS
NASDAQ · Biotechnology

Acumen Pharmaceuticals Inc

$0.21
0.00 (-1.83%)
As of Nov 15, 10:41 PM ET ·
Day Range $0.19 — $0.23
52W Range $0.19 — $3.60

Performance

1D —
1W -9.70%
1M -87.91%
3M -92.19%
6M -90.74%
1Y -90.74%
YTD -90.74%
Open$0.22
Previous Close$0.22
Day High$0.23
Day Low$0.19
52W High$3.60
52W Low$0.19
Volume—
Avg Volume13.15M
Market Cap15.48M
P/E Ratio—
EPS$-1.55
SectorBiotechnology

Technical Indicators

Full analysis →
SMA 50 $1.90 Below
RSI (14) 17.2 Oversold

Analyst Ratings

Strong Sell
11 analysts
2 Buy 4 Hold 5 Sell
Price Target +10,283.2% upside
Current
$0.21
Target
$22.22
$18.81 $22.22 avg $35.10

Key Financials

FY 2025 FY 2024 FY 2023
Revenue 32.13M 32.40M 26.28M
Net Income 3.79M 3.97M 2.79M
Profit Margin 11.8% 12.2% 10.6%
EBITDA 5.50M 6.39M 4.32M
Free Cash Flow 1.86M 2.43M 2.61M
Rev Growth +20.9% +8.5% +2.1%
Debt/Equity 0.36 0.35 0.35

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $295.03 +0.20% 50.3 520.47B
AMGN Amgen Inc $465.67 -0.30% 26.9 252.64B
GILD Gilead Sciences Inc $168.08 +0.08% — 208.95B
VRTX Vertex Pharmaceuticals Inc $538.60 -0.74% 33.9 134.82B
REGN Regeneron Pharmaceuticals $955.47 +0.45% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $165.04 +5.36% 7.7 20.98B

Quick Stats

Market Cap15.48M
P/E Ratio—
EPS$-1.55
Volume—
SectorBiotechnology